MCF Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-250
| Closed | -$9K | – | 463 |
|
2020
Q2 | $9K | Hold |
250
| – | – | ﹤0.01% | 374 |
|
2020
Q1 | $7K | Hold |
250
| – | – | ﹤0.01% | 384 |
|
2019
Q4 | $13K | Hold |
250
| – | – | ﹤0.01% | 358 |
|
2019
Q3 | $14K | Hold |
250
| – | – | ﹤0.01% | 345 |
|
2019
Q2 | $10K | Hold |
250
| – | – | ﹤0.01% | 353 |
|
2019
Q1 | $8K | Hold |
250
| – | – | ﹤0.01% | 357 |
|
2018
Q4 | $8K | Hold |
250
| – | – | ﹤0.01% | 363 |
|
2018
Q3 | $11K | Hold |
250
| – | – | ﹤0.01% | 349 |
|
2018
Q2 | $8K | Hold |
250
| – | – | ﹤0.01% | 346 |
|
2018
Q1 | $12K | Hold |
250
| – | – | ﹤0.01% | 316 |
|
2017
Q4 | $13K | Hold |
250
| – | – | ﹤0.01% | 315 |
|
2017
Q3 | $15K | Hold |
250
| – | – | ﹤0.01% | 317 |
|
2017
Q2 | $12K | Hold |
250
| – | – | ﹤0.01% | 348 |
|
2017
Q1 | $11K | Hold |
250
| – | – | ﹤0.01% | 346 |
|
2016
Q4 | $12K | Hold |
250
| – | – | ﹤0.01% | 294 |
|
2016
Q3 | $12K | Hold |
250
| – | – | ﹤0.01% | 305 |
|
2016
Q2 | $13K | Hold |
250
| – | – | ﹤0.01% | 324 |
|
2016
Q1 | $11K | Hold |
250
| – | – | ﹤0.01% | 308 |
|
2015
Q4 | $10K | Hold |
250
| – | – | ﹤0.01% | 329 |
|
2015
Q3 | $8K | Hold |
250
| – | – | ﹤0.01% | 341 |
|
2015
Q2 | $8K | Hold |
250
| – | – | ﹤0.01% | 347 |
|
2015
Q1 | $10K | Hold |
250
| – | – | ﹤0.01% | 323 |
|
2014
Q4 | $10K | Hold |
250
| – | – | ﹤0.01% | 304 |
|
2014
Q3 | $10K | Hold |
250
| – | – | ﹤0.01% | 312 |
|
2014
Q2 | $10K | Hold |
250
| – | – | ﹤0.01% | 311 |
|
2014
Q1 | $10K | Hold |
250
| – | – | ﹤0.01% | 313 |
|
2013
Q4 | $10K | Hold |
250
| – | – | ﹤0.01% | 281 |
|
2013
Q3 | $10K | Buy |
+250
| New | +$10K | 0.01% | 276 |
|